CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

Colonic drug delivery formulation

Raloxifene sprinkle composition

Extended release liquid compositions of metformin

IMMUNOMODULATORY COMPOSITIONS

Abuse-deterrent pharmaceutical compositions of opioids and other drugs

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

Methods for treating subjects with prader-willi syndrome or smith-magenis syndrome

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

USE OF MTOR INHIBITORS TO PREVENT AND REGRESS EDHESIONS AND FIBROSIS

Abuse-deterrent drug formulations

Controlled release dosage form

Microcapsules comprising a water-immiscible core and a wall comprising the salt of a lewis acid and a lewis base

Controlled release dosage form

DUAL-CHAMBER PACK FOR EXTENDED RELEASE SUSPENSION COMPOSITIONS

Process to enhance the bioactivity of Ashwagandha extracts

COMPOSITION FOR THE TREATMENT OF DISEASE

Tamper-resistant pharmaceutical compositions of opioids and other drugs

Enterically coated cysteamine, cystamine and derivatives thereof

Enterically coated cysteamine, cystamine and derivatives thereof

Enterically coated cysteamine, cystamine and derivatives thereof

Formulations for oral delivery of adsorbents in the gut

Hypromellose acetate succinate powder excellent in dissolved state and production method thereof, and production methods for composition for solid dispersion, coating composition, drug-containing particle, and solid preparation

Colloidal dispersion comprising HPMCAS

ORAL PHARMACEUTICAL FORMULATION IN THE FORM OF AN AQUEOUS SUSPENSION OF MICROCAPSULES FOR THE MODIFIED RELEASE OF ACTIVE PRINCIPLE(S).

Sustained-release formulations of topiramate

Pharmaceutical cyclosporin compositions

Arimoclomol formulation

Pharmaceutical composition of rosuvastatin calcium

METHODS AND COMPOSITIONS FOR PRODUCING HYDROGEL CAPSULES COATED FOR LOW PERMEABILITY AND PHYSICAL INTEGRITY

Controlled release dosage form

Matrix and layer compositions for protection of bioactives

Oral pharmaceutical composition

Methods and compositions for the treatment of seizure-related disorders

ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS

REDUCING DRUG LIKING IN A SUBJECT

Method of manufacturing fine particles suitable for orally disintegrating pharmaceutical dosage forms

Extended-release topiramate capsules

Metoprolol sustained-release composition and preparation method thereof

DUAL-CHAMBER PACK FOR EXTENDED RELEASE SUSPENSION COMPOSITIONS

Timed, pulsatile release systems

Compositions for treatment of attention deficit hyperactivity disorder

Compositions for treatment of attention deficit hyperactivity disorder

Stable multiparticulate pharmaceutical composition of rosuvastatin

Formulation of fat-soluble vitamin

EXTENDED-RELEASE DOSAGE FORM

Enterically coated cysteamine, cystamine and derivatives thereof

Sustained-release formulations of topiramate

Composition and method for improving stability and extending shelf life of probiotic bacteria and food products thereof

Treating pain in patients with hepatic impairment

Orally disintegrating compositions

Secnidazole formulations and use in treating bacterial vaginosis

Oral liquid compositions of guanfacine

Extended release liquid compositions of guanfacine

Enterically coated cysteamine, cystamine and derivatives thereof

Enterically coated cysteamine, cystamine and derivatives thereof

AQUEOUS ENTERIC COATING COMPOSITION

Enteric coated multiparticulate controlled release peppermint oil composition and related methods

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION AND METHOD FOR MANUFACTURING THE SAME

Controlled release dosage form for once daily administration of dimethyl fumarate

Method of freeze-drying encapsulated cells, freeze-dried encapsulated cells, compositions containing freeze-dried encapsulated cells and uses of such cells and compositions

Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof

Extended release suspension compositions

Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof

Matrix and layer compositions for protection of bioactives

Pharmaceutical Formulation

Method for treating intestinal fibrosis

Compositions for treatment of attention deficit hyperactivity disorder

Semi-permeable encapsulation system with tapered conduits for diabetes reversal

2,4-dinitrophenol formulations and methods using same

Compositions for treatment of attention deficit hyperactivity disorder

Microcapsules containing an oxidizable active, and a process for preparing the same

Pharmaceutical cyclosporin compositions

PROCESS FOR MANUFACTURING PHENYLEPHRINE RESINATE PARTICLES PHENYLEPHRINE RESINATE PARTICLES AND USE OF PHENYLEPHRINE RESINATE PARTICLES IN PHARMACEUTICAL FORMULATIONS

EXTENDED RELEASE AQUEOUS SUSPENSION OF METHYLPHENIDATE OR SALTS THEREOF

Traditional chinese medicine composition, and preparation and application thereof

METHODS OF TREATING ULCERS AND RELATED SYMPTOMS IN NON-HUMAN ANIMALS

Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome

Extended release nicotinamide formulation

Timed, pulsatile release systems

Medicinal clay preparation

Method of preparing drug agglomerate

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS

Composition comprising hydrocortisone

Pharmaceutical formulations of nitrite and uses thereof

Composition for the treatment of disease

Formulations

ORAL ADMINISTRATION PREPARATION WITH MASKED BITTERNESS OF SILODOSIN

Timed, pulsatile release systems

Sustained-release formulations of topiramate

Multiparticulate L-menthol formulations and related methods

Oral pharmaceutical composition

SEMI-PERMEABLE CAPSULAR MEMBRANE WITH TAPERED CONDUITS FOR DIABETES FUNCTIONAL CURE

Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)

Delayed-release formulations, methods of making and use thereof

Compositions for treatment of attention deficit hyperactivity disorder

Hydrazaline hydrochloride pellets and method of preparation

PHENYLEPHRINE PHARMACEUTICAL FORMULATIONS AND COMPOSITIONS FOR COLONIC ABOSORPTION

Orally disintegrating tablets and methods of manufacture

LAYERING AND MICROENCAPSULATION OF THERMAL SENSITIVE BIOLOGICALLY ACTIVE MATERIAL USING HEAT ABSORBING MATERIAL LAYERS HAVING INCREASING MELTING POINTS

Extended-release topiramate capsules

Abuse Resistant Drug Formulation

Pharmaceutical composition comprising amphetamines complexed with ion-exchange resin particles

Abuse resistant drug formulation

Pharmaceutical activated carbon composition

Method of treatment of attention deficit hyperactivity disorder

Compositions for treatment of attention deficit hyperactivity disorder

Composition of oily, pungent and odoriferous substances and a process of preparation thereof

High drug load mesalazine sachet

Multi-encapsulated formulations made with oxidized cellulose

Colonic drug delivery formulation

Filaggrin gene expression promoter

Dissolution enhanced controlled drug delivery system for poorly water soluble drugs

Matrix and layer compositions for protection of bioactives

PELLET FORMULATION FOR THE TREATMENT OF THE INTESTINAL TRACT

COATED DRUG DELIVERY FORMULATIONS

Pharmaceutical preparation and method for treatment of diabetes

Topiramate Sustained-Release Pharmaceutical Composition, Method for Preparing Same, and Uses Thereof

CONTROLLED-RELEASE PHARMACEUTICAL COMPOSITION INCLUDING TAMSULOSIN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, AND ORAL FORMULATION INCLUDING THE SAME

Exopolysaccharide for the treatment and/or care of the skin, mucous membranes and/or nails

Abuse resistant forms of immediate release oxymorphone, method of use and method of making

Abuse resistant forms of extended release hydrocodone, method of use and method of making

ABUSE RESISTANT FORMS OF EXTENDED RELEASE HYDROMORPHONE, METHOD OF USE AND METHOD OF MAKING

ABUSE RESISTANT FORMS OF IMMEDIATE RELEASE HYDROCODONE, METHOD OF USE AND METHOD OF MAKING

Abuse resistant forms of extended release oxymorphone, method of use and method of making

Abuse resistant forms of immediate release hydromorphone, method of use and method of making

Treating pain in patients with hepatic impairment

Oral pharmaceutical compositions of dabigatran etexilate

Tamper-resistant pharmaceutical compositions of opioids and other drugs

Abuse resistant forms of extended release morphine, method of use and method of making

Multiparticulate L-carnitine compositions and related methods

Enteric coated multiparticulate controlled release peppermint oil composition and related methods

Sustained-release formulations of topiramate

Drug delivery system for sustained delivery of bioactive agents

Formulation for the controlled release of one or several substances in the digestive tract of a mammal

Treatment of adrenal insufficiency

Orally disintegrable tablets

Extended-release topiramate capsules

Modified release pharmaceutical compositions of dexlansoprazole

Abuse resistant forms of extended release morphine, method of use and method of making

Abuse resistant forms of extended release morphine, method of use and method of making

Coating system

Method for treating intestinal fibrosis

ORGANIC COMPOUNDS

Orally disintegrating tablet compositions of lamotrigine

Coating composition, drug-containing particle, solid preparation and method for preparing drug-containing particle

CONTROLLED RELEASE PREPARATION

CONTROLLED RELEASE PREPARATION

Orally disintegrating tablets and methods of manufacture

Enteric delivery of functional ingredients suitable for hot comestible applications

Fexofenadine microcapsules and compositions containing them

Compositions comprising methylphenidate complexed with ion-exchange resin particles

Solventless mixing process for coating pharmaceutical ingredients

Taste masked active pharmaceutical powder compositions and processes for making them

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans

Drug delivery systems comprising solid solutions of weakly basic drugs

Composition comprising a mixture of dextro- and levo-amphetamines complexed with ion-exchange resin particles to form drug resin particles

Microencapsulation process and product

CONTROLLED RELEASE COMPOSITIONS OF GAMMA-HYDROXYBUTYRATE

Compositions comprising methylphenidate complexed with ion-exchange resin particles

GRANULES IN LIQUID DOSAGE FORM

Oxidized cellulose miczrospheres including visualization agents

Pharmaceutical cyclosporin compositions

Pellet formulation for the treatment of the intestinal tract

Immunomodulatory compositions

Composition comprising a mixture of dextro- and levo-amphetamines complexed with ion-exchange resin particles to form drug resin particles

Method for treating ADD or ADHD comprising administering amphetamine complexed with ion-exchange resin particles

Pharmaceutical composition for transcolonic absorption

Substituted cellulose acetates and uses thereof

Particles of tetracyclines and protecting agent

pH-dependent gradual release pharmaceutical composition

Pellet formulation for the treatment of the intestinal tract

Pellet formulation for the treatment of the intestinal tract

Abuse resistant drug formulation

Method for treating celiac disease

Polyvalent polymeric matrix for modified release solid oral preparations and method of preparation thereof

Orally disintegrating tablet compositions of lamotrigine

Rapid Melt Controlled Release Taste-Masked Compositions

Formulations for oral delivery of adsorbents in the gut

Degradable microcapsules

METHOD FOR STABLE AND CONTROLLED DELIVERY OF (-)-HYDROXYCITRIC ACID

ORAL PHARMACEUTICAL COMPOSITION COMPRISING FENOFIBRIC ACID AND AN ALKALIFYING AGENT

Granules for pharmaceutical preparations, methods and apparatus for their production

Controlled release pharmaceutical compositions of tapentadol

Controlled Release Formulations of Opioids

ORAL VACCINES PRODUCED AND ADMINISTERED USING EDIBLE MICRO-ORGANISMS INCLUDING LACTIC ACID BACTERIAL STRAINS

METHOD AND COMPOSITION FOR STABLE AND CONTROLLED DELIVERY OF (-)-HYDROXYCITRIC ACID

Coating method

Pharmaceutical composition

Sustained-release formulations of topiramate

Pharmaceutical or neutraceutical formulation

Multiparticulate L-carnitine compositions and related methods

PARTICULATE PREPARATION AND METHOD FOR PRODUCING THE SAME

Pellet formulation for the treatment of the intenstinal tract

ORGANIC COMPOUNDS

BARRIER COMPOSITION

Oral pharmaceutical composition

ENTERICALLY COATED CYSTEAMINE, CYSTAMINE AND DERIVATIVES THEREOF

Controlled release compositions of gamma-hydroxybutyrate

SUSTAINED RELEASE CANNABINOID MEDICAMENTS

Multiparticulate L-menthol formulations and related methods

PHARMACEUTICAL COMPOSITIONS FOR REDUCING ALCOHOL-INDUCED DOSE DUMPING

Pharmaceutical formulation

Beta 2 adrenergic receptor agonists such as terbutaline for use in the treatment of nocturnal hypoglycemia

Pharmaceutical dosage form

Abuse resistant oral opioid formulations

Abuse resistant forms of immediate release oxycodone, method of use and method of making

Timed, pulsatile release systems

ORAL FORMULATIONS

Morphine Formulations

Polymer shells

Coated drug delivery formulations

Enterically coated cysteamine, cystamine and derivatives thereof

ORAL ENTERIC ANTIDEPRESSANT FORMULATION

CONTROLLED RELEASE COMPOSITIONS COMPRISING ANTI-CHOLINERGIC DRUGS

Composition based on gamma-hydroxybutyric acid

Sustained-release formulations of topiramate

Sustained-release formulations of topiramate

Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans

Modified release pharmaceutical compositions of dexlansoprazole

ORALLY DISNTEGRATING TABLETS FOR THE TREATMENT OF PAIN

MULTICOATED ALISKIREN FORMULATIONS

CONTROLLED RELEASE COMPOSITIONS COMPRISING MECLIZINE OR RELATED PIPERAZINE DERIVATIVES

Fexofenadine microcapsules and compositions containing them

Compositions and methods for inhibiting gastric acid secretion

Dosage forms that facilitate rapid activation of barley protease zymogen

CONTROLLED-RELEASE MICROPARTICLES AND METHOD OF PREPARING SAME

Method of using combination preparation comprising angiotensin-II-receptor blocker and HMG-CoA reductase inhibitor

COMBINATION PREPARATION COMPRISING ANGIOTENSIN-II-RECEPTOR BLOCKER AND HMG-COA REDUCTASE INHIBITOR

Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics

Controlled Release Formulations of Opioids

HYDROPHILIC AMINO ACID-CONTAINING PREPARATION HAVING IMPROVED TASTE

Pharmaceutical compositions configured to deter dosage form splitting

Degradable microcapsules

Microencapsulate and process for the manufacture thereof

Extended release venlafaxine formulation

Modified release pharmaceutical compositions

Abuse resistant drugs, method of use and method of making

Abuse resistant forms of extended release morphine, method of use and method of making

Abuse resistant forms of extended release morphine with oxycodone, method of use and method of making

Abuse resistant forms of extended release hydrocodone, method of use and method of making

Abuse resistant forms of extended release oxymorphone, method of use and method of making

Abuse resistant forms of extended release oxycodone, method of use, and method of making

Abuse resistant forms of extended release hydromorphone, method of use and method of making

Extended release compositions comprising tolterodine

Tamper-resistant pharmaceutical compositions of opioids and other drugs

EXTENDED-RELEASE DOSAGE FORM

Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)

Magnetic particles

Compositions and methods for inhibiting gastric acid secretion

PHARMACEUTICAL FORMULATION

Methods and compositions for producing hydrogel capsules coated for low permeability and physical integrity

Pharmaceutical composition containing L. extracts for lowering blood glucose

Benzonatate compositions and methods of use

Pharmaceutical formulations of nitrite and uses thereof

ORALLY DISINTEGRABLE TABLETS

Abuse resistant drugs, method of use and method of making

PHARMACEUTICAL PREPARATION FOR TREATING CARDIOVASCULAR DISEASE

FORMULATIONS OF FLIBANSERIN

STABLE BENZIMIDAZOLE FORMULATION

USE OF 5-AMINOLEVULINIC ACID AND DERIVATIVES IN A SOLID FORM FOR PHOTODYNAMIC TREATMENT AND DIAGNOSIS

Abuse resistant oral opioid formulations

HIGH BIOAVAILABILITY FORMULATION OF MANGOSTEEN AND MANUFACTURING PROCESS THEREOF

PHARMACEUTICAL COMPOSITIONS COMPRISING N-[2-(DIETHYLAMINO)ETHYL]-5-[(5-FLUORO-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)METHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE

Orally disintegrating tablet compositions of lamotrigine

MULTIPLE UNIT PHARMACEUTICAL FORMULATION

Pharmaceutical composition of tacrolimus

Controlled release preparation

PHARMACEUTICAL COMPOSITIONS OF RHEIN OR DIACEREIN

SOLID PHARMACEUTICAL COMPOSITION COMPRISING 1-(4-CHLOROANILINO)-4-(4-PYRIDYLMETHYL)PHTHALAZINE AND A PH MODIFIER

Method for treating celiac disease

Controlled release preparation

METHOD FOR STABLE AND CONTROLLED DELIVERY OF (-)-HYDROXYCITRIC ACID

CONTROLLED RELEASE PREPARATION

ORAL PARTICULATE ANTITUMOR PREPARATION

Abuse-deterrent drug formulations

Immobilization particles for targeted removal of microorganisms and substances

Oral pharmaceutical composition

Composition for foodstuff for binding acetaldehyde

Oral Pharmaceutical Formulations Containing Non-Steroidal Anti-Inflammatory Drugs and Acid Inhibitors

Abuse-Resistant Pharmaceutical Dosage Form

PHARMACEUTICAL COMPOSITION CONTAINING MICRONIZED PARTICLES OF NAPHTHOQUINONE-BASED COMPOUND

Pharmaceutical cyclosporin compositions

PHARMACEUTICAL COMPOSITION IN THE FORM OF COATED MICROSPHERES FOR THE MODIFIED RELEASE OF A MUSCLE RELAXANT AND AN NSAID

Compositions Comprising Melperone and Controlled-Release Dosage Forms

Method for treating infectious organisms normally considered to be resistant to an antimicrobial drug

Multiparticulates of spray-coated drug and polymer on a meltable core

COMPLEX FORMULATION FOR PREVENTING OR TREATING OSTEOPOROSIS WHICH COMPRISES SOLID DISPERSION OF VITAMIN D OR ITS DERIVATIVE AND BISPHOSPHONATE

ORGANIC COMPOUNDS

Use of Sucralose as a Granulating Agent

COMPOSITION AND COMBINATIONS OF CARBOXYLIC ACID LOSARTAN IN DOSAGE FORMS

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

Pellet-form slow-release preparation for vertigo

Multiple Unit Tablets

Palatable, solid oral formulations for male chemical sterilization

Controlled Release Pharmaceutical Composition of Venlafaxine Hydrochloride, and Process for Preparation Thereof

COMPOSITION AND METHOD FOR BINDING ACETALDEHYDE IN STOMACH

Drug delivery systems comprising weakly basic drugs and organic acids

Controlled Release Muscarinic Receptor Antagonist Formulation